Skip to Content

Barrett’s and Esophageal Adenocarcinoma Consortium

The International Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON) was established in 2005 with support from the National Cancer Institute. BEACON is composed of over three dozen investigators with completed or ongoing epidemiologic studies of Barrett’s esophagus and/or esophageal adenocarcinoma. This open scientific forum now has more than 50 members who have research interests in the etiology and prevention of these diseases. The current chair is Dr. Thomas L. Vaughan, a Professor of Epidemiology at the Fred Hutchinson Cancer Research Center. 

Analyses from the BEACON group so far have included alcohol consumption, anthropometry, cigarette smoking, excess risk models, gastroesophageal reflux disease, non-steroidal anti-inflammatory drugs, reproductive factors, and genome-wide studies to identify susceptibility loci associated with Barrett’s esophagus and/or adenocarcinomas of the esophagus.

Search for publications by BEACON members.

For more information, contact Michael Cook.